Privacy Policy
The Effective Date of this Privacy Policy is April 22, 2011.
SUMMARY AND GENERAL CONTACT INFORMATION
This Privacy Policy describes how we handle information we learn about you from...
Careers at Pulmonx
Pulmonx is focused on developing life-changing, cost-effective technologies that improve the lives of patients suffering from lung disease, and we are looking for individuals who...
Contact Us
For general inquiries please fill out the Information Request Form.
Pulmonx Corporation
700 Chesapeake Drive Redwood City, CA 94063 United States Tel: +1 (650) 364-0400 Fax: +1 (650)...
Chartis® System
The Chartis System is a proprietary pulmonary assessment tool that enables physicians to identify those patients likely to respond to the Pulmonx Zephyr valves with a high degree of...
Zephyr® Endobronchial Valve
The Zephyr Endobronchial Valve is an endoscopic lung volume reduction therapy designed to significantly improve lung function, exercise capacity and quality of life for...
Emphysema Can Be a Burden
Emphysema – a severe form of Chronic Obstructive Pulmonary Disease (COPD) – is a progressive disease that traps air in the air sacs in your lungs (alveoli) and causes...
LIBERATE Study Survey
The pre-screening questionnaire is the first step toward participating in the LIBERATE Zephyr®Endobronchial Valve Trial. In the United States, the Zephyr Valve is an...
